122 related articles for article (PubMed ID: 36651958)
1. Occurrence and Severity of Suicidal Ideation in Adults With Neurofibromatosis Participating in a Mind-Body RCT.
Lester EG; Wang KE; Blakeley JO; Vranceanu AM
Cogn Behav Neurol; 2023 Mar; 36(1):19-27. PubMed ID: 36651958
[TBL] [Abstract][Full Text] [Related]
2. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.
Mace RA; Doorley J; Bakhshaie J; Cohen JE; Vranceanu AM
J Neurooncol; 2021 Nov; 155(2):125-132. PubMed ID: 34570301
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.
Fishbein NS; Vranceanu AM; Mace RA
J Neurooncol; 2022 Sep; 159(3):637-646. PubMed ID: 35925531
[TBL] [Abstract][Full Text] [Related]
4. Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.
Doorley JD; Greenberg J; Bakhshaie J; Fishbein NS; Vranceanu AM
J Neurooncol; 2021 Sep; 154(2):257-263. PubMed ID: 34409538
[TBL] [Abstract][Full Text] [Related]
5. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
[TBL] [Abstract][Full Text] [Related]
6. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
[TBL] [Abstract][Full Text] [Related]
7. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
[TBL] [Abstract][Full Text] [Related]
8. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
[TBL] [Abstract][Full Text] [Related]
9. Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.
Reichman M; Riklin E; Macklin E; Vranceanu AM
Contemp Clin Trials; 2020 Aug; 95():106078. PubMed ID: 32634485
[TBL] [Abstract][Full Text] [Related]
10. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
Lester EG; Gates MV; Vranceanu AM
Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
[TBL] [Abstract][Full Text] [Related]
11. The importance of suicide risk assessment in patients affected by neurofibromatosis.
Berardelli I; Maraone A; Belvisi D; Pasquini M; Giustini S; Miraglia E; Iacovino C; Pompili M; Frascarelli M; Fabbrini G
Int J Psychiatry Clin Pract; 2021 Nov; 25(4):350-355. PubMed ID: 34270353
[TBL] [Abstract][Full Text] [Related]
12. The effect of a therapeutic smartphone application on suicidal ideation in young adults: Findings from a randomized controlled trial in Australia.
Torok M; Han J; McGillivray L; Wong Q; Werner-Seidler A; O'Dea B; Calear A; Christensen H
PLoS Med; 2022 May; 19(5):e1003978. PubMed ID: 35639672
[TBL] [Abstract][Full Text] [Related]
13. The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.
Vranceanu AM; Merker VL; Plotkin SR; Park ER
J Neurooncol; 2014 Oct; 120(1):103-9. PubMed ID: 25022450
[TBL] [Abstract][Full Text] [Related]
14. Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.
Lester E; DiStefano S; Mace R; Macklin E; Plotkin S; Vranceanu AM
Gen Hosp Psychiatry; 2020; 62():72-78. PubMed ID: 31841875
[TBL] [Abstract][Full Text] [Related]
15. Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.
Carter S; Greenberg J; Funes CJ; Macklin EA; Vranceanu AM
Complement Ther Med; 2021 Jan; 56():102581. PubMed ID: 33197677
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of suicidal ideation in patients with chronic non-cancer pain referred to a behaviorally based pain program.
Cheatle MD; Wasser T; Foster C; Olugbodi A; Bryan J
Pain Physician; 2014; 17(3):E359-67. PubMed ID: 24850117
[TBL] [Abstract][Full Text] [Related]
17. The impact of the COVID-19 Pandemic on the Greek population: Suicidal ideation during the first and second lockdown.
Gournellis R; Efstathiou V
Psychiatriki; 2021 Dec; 32(4):267-270. PubMed ID: 34860683
[TBL] [Abstract][Full Text] [Related]
18. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
19. Suicidal ideation among Lebanese adults: scale validation and correlates.
Zakhour M; Haddad C; Sacre H; Fares K; Akel M; Obeid S; Salameh P; Hallit S
BMC Psychiatry; 2021 Feb; 21(1):100. PubMed ID: 33593321
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Suicidal Ideation in Patients with Chronic Non-Cancer Pain.
Racine M; Sánchez-Rodríguez E; Gálan S; Tomé-Pires C; Solé E; Jensen MP; Nielson WR; Miró J; Moulin DE; Choinière M
Pain Med; 2017 Feb; 18(2):283-293. PubMed ID: 28204732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
